Anastasia Budinskaya brings broad experience as an entrepreneur, operator, and investor to the NFX Bio team. Before joining NFX, Anastasia was a Sr. Manager of Operations & Strategy at One Mind Accelerator, focused on investing in innovative mental health companies. Venture Associate at Gilde Healthcare Partners, where she was part of a small team overseeing the US MedTech investment portfolio. Prior to her transition in to Venture Capital, she was acquihired into GE HealthCare as a Scientific Leader in Neurology, where she designed clinical studies and led technology transfer for the in-licensing of Altropane into the GE Pharmaceutical Diagnostics portfolio from the start-up, LikeMinds. At LikeMinds, Anastasia led Corporate and Clinical Development under the CEO and CMO and contributed significantly to the out-licensing of Altropane.

She holds an M.S. in Bioengineering Biomechanical Systems and Devices from Tufts University and a B.S. in Bioengineering from Syracuse University.